Healthlead Valuation
Is HL-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of HL-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HL-R (THB11.6) is trading above our estimate of fair value (THB10.28)
Significantly Below Fair Value: HL-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HL-R?
Other financial metrics that can be useful for relative valuation.
What is HL-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿3.16b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.7x |
Enterprise Value/EBITDA | 22.3x |
PEG Ratio | 3x |
Price to Earnings Ratio vs Peers
How does HL-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 14.7x | ||
TNP Thanapiriya | 17.3x | n/a | ฿2.7b |
PM Premier Marketing | 11.1x | n/a | ฿4.4b |
WINNER Winner Group Enterprise | 11.4x | n/a | ฿1.3b |
SVT Sun Vending Technology | 19.1x | n/a | ฿1.1b |
HL-R Healthlead | 42.3x | 14.2% | ฿3.2b |
Price-To-Earnings vs Peers: HL-R is expensive based on its Price-To-Earnings Ratio (42.3x) compared to the peer average (14.7x).
Price to Earnings Ratio vs Industry
How does HL-R's PE Ratio compare vs other companies in the Asian Consumer Retailing Industry?
Price-To-Earnings vs Industry: HL-R is expensive based on its Price-To-Earnings Ratio (42.3x) compared to the Asian Consumer Retailing industry average (17.3x).
Price to Earnings Ratio vs Fair Ratio
What is HL-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 42.3x |
Fair PE Ratio | 20.2x |
Price-To-Earnings vs Fair Ratio: HL-R is expensive based on its Price-To-Earnings Ratio (42.3x) compared to the estimated Fair Price-To-Earnings Ratio (20.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.